4.7 Review

Hypophosphatemia in critically ill adults and children-A systematic review

Journal

CLINICAL NUTRITION
Volume 40, Issue 4, Pages 1744-1754

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.clnu.2020.09.045

Keywords

Phosphate; Hypophosphatemia; Critical illness; Refeeding syndrome; Prevalence; Outcome

Funding

  1. European Society of Intensive Care Medicine (ESICM)

Ask authors/readers for more resources

This systematic review identified significant variations in the prevalence of hypophosphatemia among critically ill patients, with its association with adverse outcomes such as prolonged hospital stay, need for respiratory support, and higher mortality. However, there is insufficient evidence regarding the optimal threshold for critical hypophosphatemia, frequency of phosphate measurements, and timing for correcting hypophosphatemia.
28 prospective and 31 retrospective studies, and 20 case reports. Relevant risk of bias regarding selection and comparability was identified for most of the studies. No meta-analysis could be performed. The prevalence of hypophosphatemia varied substantially in critically ill adults and children, but no study assessed consecutive admissions to intensive care. In both critically ill adults and children, several studies report that hypophosphatemia is associated with worse outcome (prolonged length of stay and the need for respiratory support, and higher mortality). However, there was insufficient evidence regarding the optimal threshold upon which hypophosphatemia becomes critical and requires treatment. We found no studies regarding the optimal frequency of phosphate measurements, and regarding the time window to correct hypophosphatemia. In adults, nutrient restriction on top of phosphate repletion in patients with refeeding syndrome may improve survival, although evidence is weak. Conclusions: Evidence on the definition, outcome and treatment of clinically relevant hypophosphatemia Background & aims: Phosphate is the main intracellular anion essential for numerous biological processes. Symptoms of hypophosphatemia are non-specific, yet potentially life-threatening. This systematic review process was initiated to gain a global insight into hypophosphatemia, associated morbidity and treatments. Methods: A systematic review was conducted (PROSPERO CRD42020163191). Nine clinically relevant questions were generated, seven for adult and two for pediatric critically ill patients, and prevalence of hypophosphatemia was assessed in both groups. We identified trials through systematic searches of Medline, EMBASE, Scopus, Cochrane Central Register of Controlled Trials, CINAHL, and Web of Science. Quality assessment was performed using the Cochrane risk of bias tool for randomized controlled trials and the Newcastle-Ottawa Scale for observational studies. Results: For all research questions, we identified 2727 titles in total, assessed 399 full texts, and retained 82 full texts for evidence synthesis, with 20 of them identified for several research questions. Only 3 randomized controlled trials were identified with two of them published only in abstract form, as well as

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available